Kangmei Pharmaceutical Co Ltd (600518) — Capital Reinvestment Ratio
Kangmei Pharmaceutical Co Ltd (600518) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥219.96 Million) in capital expenditures (CN¥48.57 Million). See 600518 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kangmei Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2021)
This chart tracks Kangmei Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check how aggressively does Kangmei Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kangmei Pharmaceutical Co Ltd (1999–2021)
Year-by-year Capital Reinvestment Ratio for Kangmei Pharmaceutical Co Ltd from 1999 to 2021. For live market cap and broader valuation context, see market value of Kangmei Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.80x | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥1.03 Billion | CN¥301.73 Million | ▲ +78.2% |
| 2019 | 0.16x | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.9% |
| 2018 | 15.03x | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1437.2% |
| 2016 | 0.98x | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.70x | CN¥508.86 Million | CN¥1.37 Billion | ▲ +348.5% |
| 2014 | 0.60x | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥30.25 Million | CN¥12.96 Million | — |